Skip to main content

Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa

Project description

Vulnerable populations may soon have a shield against Schistosomiasis

Poor communities, particularly in developing countries in Africa, often do not have access to potable water and adequate sanitation, increasing the threatening presence of pathogens and pathogen-carrying organisms. Six species of Schistosoma, a parasitic blood worm, penetrate the skin of people exposed to freshwater infested with the larvae. As the worms mature, they travel through the circulatory system, eventually infecting and causing massive damage to many tissues and organs. VASA is pushing a promising trademarked candidate vaccine through the clinical pipeline while ensuring access in areas with limited resources. Backed by a global consortium, VASA is dedicated to the eradication of Schistosomiasis.

Call for proposal

H2020-SC1-2018-Two-Stage-RTD
See other projects for this call

Coordinator

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Address
Trinity Lane The Old Schools
CB2 1TN Cambridge
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 339 331,09

Participants (9)

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands
EU contribution
€ 612 856,45
Address
Albinusdreef 2
2333 ZA Leiden
Activity type
Higher or Secondary Education Establishments
GOETEBORGS UNIVERSITET
Sweden
EU contribution
€ 350 000,19
Address
Vasaparken
405 30 Goeteborg
Activity type
Higher or Secondary Education Establishments
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany
EU contribution
€ 41 250
Address
Geschwister-scholl-platz
72074 Tuebingen
Activity type
Higher or Secondary Education Establishments
GROUPE DE RECHERCHE ACTION EN SANTE SARL
Burkina Faso
EU contribution
€ 643 812,51
Address
Secteur 25 Somgande Rue 25 26 Porte 79
06 Ouagadougou
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY OF ANTANANARIVO
Madagascar
EU contribution
€ 864 420,38
Address
Campus D'ankatso
101 Antananarivo
Activity type
Higher or Secondary Education Establishments
UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO
Burkina Faso
EU contribution
€ 259 672,78
Address
.
03 Ouagadougou 03
Activity type
Higher or Secondary Education Establishments
TEXAS TECH UNIVERSITY SYSTEM
United States
EU contribution
€ 704 831,24
Address
1508 Knoxville Avenue
79409 Lubbock
Activity type
Higher or Secondary Education Establishments
PAI LIFE SCIENCES INC.
United States
EU contribution
€ 387 290
Address
251 Little Falls Drive
19808 Wilmington
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INTERNATIONAL VACCINE INSTITUTE
South Korea
EU contribution
€ 1 415 877,66
Address
San 4-8 Bongcheon-7 Dong, Kwanak Gu
151919 Seoul
Activity type
Research Organisations